Onychomycosis
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Onychomycosis Classification and external resources | |
 | |
|---|---|
| A toenail affected by Onychomycosis | |
| ICD-10 | B35.1 |
| ICD-9 | 110.1 |
| DiseasesDB | 13125 |
| MedlinePlus | 001330 |
| eMedicine | derm/300 |
| MeSH | D014009 |
|
WikiDoc Resources for Onychomycosis | |
|
Articles | |
|---|---|
|
Most recent articles on Onychomycosis Most cited articles on Onychomycosis | |
|
Media | |
|
Powerpoint slides on Onychomycosis | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Onychomycosis at Clinical Trials.gov Trial results on Onychomycosis Clinical Trials on Onychomycosis at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Onychomycosis NICE Guidance on Onychomycosis
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Onychomycosis Discussion groups on Onychomycosis Patient Handouts on Onychomycosis Directions to Hospitals Treating Onychomycosis Risk calculators and risk factors for Onychomycosis
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Onychomycosis | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Onychomycosis means fungal infection of the nails. It represents up to 20% of all nail disorders.
This condition may affect toe- or fingernails, but toenail infections are particularly common. The prevalence of onychomycosis is about 6-8% in the adult population.[1] The most common type of onychomycosis (80-90%), caused by dermatophytes, is technically known as tinea unguium (tinea of the nails).[1]
Symptoms
The nail plate can have a thickened, yellow, or cloudy appearance. The nails can become rough and crumbly, or can separate from the nail bed. There is usually no pain or other bodily symptoms, unless the disease is severe. [1]
Dermatophytids are fungus-free skin lesions that sometimes form as a result of a fungus infection in another part of the body. This could take the form of a rash or itch in an area of the body that is not infected with the fungus. Dermatophytids can be thought of as an allergic reaction to the fungus.
Causes
Dermatophytes are the fungi most commonly responsible for onychomycosis. Two dermatophyte species, Trichophyton rubrum and Trichophyton interdigitale, cause the vast majority of onychomycosis cases worldwide. Other related dermatophyte fungi that may be involved are Epidermophyton floccosum, Trichophyton violaceum, Microsporum gypseum, Trichophyton tonsurans, Trichophyton soudanense (considered by some to be an African variant of T. rubrum rather than a full-fledged separate species) and the cattle ringworm fungus Trichophyton verrucosum. A common outdated name that may still be reported by medical laboratories is Trichophyton mentagrophytes for T. interdigitale. The name T. mentagrophytes is now restricted to the agent of favus skin infection of the mouse; though this fungus may be transmitted from mice and their danders to humans, it generally infects skin and not nails.
Other causal fungi include yeasts (5-17%), e.g., Candida, and non-dermatophytic moulds, in particular members of the mould genera Scytalidium (name recently changed to Neoscytalidium), Scopulariopsis, and Aspergillus. Yeasts mainly cause fingernail onychomycosis in people whose hands are often submerged in water. Scytalidium mainly affects people in the tropics, though it persists if they later move to areas of temperate climate.
Other moulds mainly affect people over the age of 60, and their presence in the nail reflects a slight weakening in the nail's ability to defend itself against fungal invasion.
Classification
- Distal Subungual Onychomycosis
- The most common form of tinea unguium usually caused by Trichophyton rubrum, which invades the nail bed and the underside of the nail plate.
- White Superficial Onychomycosis
- Caused by fungal invasion of the superficial layers of the nail plate to form "white islands" on the plate. Accounts for only 10 percent of onychomycosis cases.
- Proximal Subungual Onychomycosis
- Fungal penetration of the newly formed nail plate through the proximal nail fold. It is the least common form of tinea unguium in healthy people but found more commonly when the patient is immunocompromised.
- Candidal Onychomycosis
- Candida species invade fingernails usually occurring in persons who frequently immerse their hands in water. This normally requires the prior damage of the nail by infection or trauma.
- Total Dystrophic Onychomycosis
- Total destruction of the nail plate. It is the end result of any of the above four types.
Diagnosis
If all nails are affected then fungal infection is improbable. To avoid misdiagnosis as psoriasis, lichen planus, contact dermatitis, trauma, nail bed tumor or yellow nail syndrome, laboratory confirmation may be necessary. The three main approaches are potassium hydroxide smear, culture and histology. This involves microscopic examination and culture of nail scrapings or clippings. Recent results indicate that the most sensitive diagnostic approaches are direct smear combined with histological examination[1] and nail plate biopsy using periodic acid-Schiff stain[1].
Treatment
Treatment of onychomycosis is challenging because the infection is embedded within the nail and is difficult to reach. As a result full removal of symptoms is very slow and may take a year or more.
Pharmacologic Rx
Most treatments are either systemic antifungal medications such as terbinafine and itraconazole, or topical such as nail paints containing ciclopirox or amorolfine. There is also evidence for combining systemic and topical treatments.[1]
Natural remedies
As with many diseases, there are also some scientifically unverified folk or alternative medicine remedies.
- Grapefruit seed extract as a natural antimicrobial is not demonstrated. Its effectiveness is scientifically unverified. Multiple studies indicate that the universal antimicrobial activity is due to contamination with synthetic preservatives that were unlikely to be made from the seeds of the grapefruit.[1][1][1][1][1]
- Distilled white vinegar. Drops are applied to the cuticle twice a day. This method does not kill the fungus, but the vinegar allegedly changes the pH (acid content) of the new nail formed in that 12-hour period. (The scientific perspective, however, is that vinegar is unlikely to penetrate the dense keratinous tissue thoroughly enough to have any significant effect. Instead, it may be absorbed by the skin above the nail and work its way to where the nail is actually forming.) As the old, infected nail grows and is cut away, it is said to be replaced by an acidic nail, uninhabitable by fungi. Several months of consistent application are involved.
Relative effectiveness of treatments
In July 2007 a meta-study reported on clinical trials for topical treatments of fungal nail infections. The study included 6 randomised controlled trials dating up to March 2005[1]. The main findings are:
- There is some evidence that ciclopiroxolamine and butenafine are both effective but both need to be applied daily for prolonged periods (at least 1 year).
- There is evidence that topical ciclopiroxolamine has poor cure rates and that amorolfine might be substantially more effective.
- Further research into the effectiveness of antifungal agents for nail infections is required.
A 2002 study compared the efficacy and safety of terbinafine in comparison with placebo, itraconazole and griseofulvin in treating fungal infections of the nails.[1] The main findings were that for reduced fungus terbinafine was found to be significantly better than itraconazole and griseofulvin, and terbinafine was better tolerated than itraconazole.
- A small study in 2004 showed that ciclopirox nail paint was more effective when combined with topical urea cream.[1]
- A study of 504 patients in 2007 found that aggressive debridement of the nail combined with oral terbafine significantly reduced symptom frequency over terbafine alone.[1]
- A 2007 randomised clinical trial with 249 patients show that a combination of amorolfine nail lacquer and oral terbinafine enhances clinical efficacy and is more cost-effective than terbinafine alone.[1]
New developments
- A medicinal nail lacquer, NM100060 from NexMed is in Phase III clinical trials[1]. It contains terbinafine as the active ingredient and a permeation enhancer which facilitates the delivery of the drug into the nail bed where the fungus resides. Commercial sale of the product is expected to begin no earlier than in 2008. [1]
- A topical treatment, AN-2690, is being developed by Schering-Plough Corp. It is active against Trichophyton species. Phase II and IIb trials are underway. [1]
Active clinical trials investigating Onychomycosis: [2].
Prevention
- Avoid walking barefoot in public areas such as showers, communal changing rooms.
- Avoid sharing shoes and socks
References
See also
External Links
Infectious diseases - Mycoses (B35-B49, 110-118) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Superficial and cutaneous |
| ||||||||
| Subcutaneous, systemic, and opportunistic |
| ||||||||
he:פטרת הציפורניים lt:Onichomikozė nl:Kalknagelzh-yue:灰甲
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
